Genomics
Five things for pharma marketers to know: Friday, December 8, 2017
December 08, 2017FDA approves first nebulized LAMA COPD treatment; more than 2,000 cancer immunotherapies in development; FDA issues 3D-printing guidance
Five things for pharma marketers to know: Thursday, June 29, 2017
June 29, 2017Walgreens ends merger with Rite Aid; Biogen hires former Novartis exec as SVP of corporate affairs; FDA takes new measures to drive drug pricing competition
Brandi Davis-Dusenbery, Seven Bridges
April 04, 2017Brandi Davis-Dusenbery is CEO of Seven Bridges.
Five things for pharma marketers to know: Tuesday, January 10, 2017
January 10, 2017Illumina and IBM enter DNA sequencing partnership; J&J to outline price increases in new report; Egalet's opioid Arymo ER gets FDA approval
Five things for pharma marketers to know: Tuesday, November 22, 2016
November 22, 2016Intarcia submits diabetes drug-delivery pump for FDA approval; Shire to build rare-disease innovation hub; AstraZeneca to resume durvalumab trials
Five things for pharma marketers to know: Friday, April 22, 2016
April 22, 2016AstraZeneca to sequence two million genomes; Valeant considering Perrigo CEO as its new chief executive; AMA and PhRMA each spent $6 million on lobbying
Clinton tells pharma to explain drug prices
June 16, 2015Speakers at Klick Health's event criticized, lauded the role of technology in healthcare.
